MedTrace Logo

Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice

NCT00177099 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2006-11-13

No results posted yet for this study

Summary

The purpose of this study is to determine if immunophilin ligands may have the potential to reverse hair loss.

Conditions

Interventions

DRUG

FK506, GP11046, GP11511

Sponsors & Collaborators

  • Hordinsky, Maria K., MD

    lead INDIV

Principal Investigators

  • Marna Ericson, Ph D · University of Minnesota

  • Maria Hordinsky, MD · University of Minnesota

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-07-31
Completion
2004-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00177099 on ClinicalTrials.gov